98%
921
2 minutes
20
Neonatal jaundice is common and can cause severe hyperbilirubinemia if untreated. The early identification of at-risk newborns is challenging despite the existing guidelines. This study aimed to identify the key maternal and neonatal risk factors for jaundice requiring phototherapy using machine learning. In this study hospital, phototherapy was administered following the American Academy of Pediatrics (AAP) guidelines when a neonate's transcutaneous bilirubin level was in the high-risk zone. To identify the risk factors for phototherapy, we retrospectively analyzed the electronic medical records of 8242 neonates admitted between 2017 and 2022. Predictive models were trained using maternal and neonatal data. XGBoost showed the best performance (AUROC = 0.911). SHAP values interpreted the model. Mode of delivery, neonatal feeding indicators (including daily formula intake and breastfeeding frequency), maternal BMI, and maternal white blood cell count were strong predictors. Cesarean delivery and lower birth weight were linked to treatment need. Machine learning models using perinatal data accurately predict the risk of neonatal jaundice requiring phototherapy, potentially aiding early clinical decisions and improving outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12384310 | PMC |
http://dx.doi.org/10.3390/children12081020 | DOI Listing |
Int J Pediatr Otorhinolaryngol
September 2025
ENT Department, AlShifa Medical Complex, Gaza, Palestine.
Introduction: Congenital hearing loss (CHL) is a significant chronic condition affecting children's development and communication skills. Globally, its incidence is 1.33 per 1000 newborns, but data from Gaza is limited, this study aims to investigate clinical profile, and risk factors associated with congenital hearing loss (CHL) in infants within the Gaza Strip, focusing on the period before the 2023 military escalation.
View Article and Find Full Text PDFJ Perinat Neonatal Nurs
September 2025
Author Affiliations: Department of Radiodiagnosis, Livasa Hospital, Sahibzada Ajit Singh Nagar, India (Dr A. Yadav); Advanced Pediatric Center, Post Graduate Institute of Medical Education and Research, Chandigarh, India (Drs Sivagnanaganesan, J. Yadav, J. Kumar); Department of Pediatrics, All India
Background And Objectives: In vitro studies suggest that oral zinc supplementation reduces enterohepatic circulation of unconjugated bilirubin and serum bilirubin levels. Multiple randomized controlled trials (RCTs) have assessed the efficacy of oral zinc supplementation in reducing bilirubin levels and the need for phototherapy. However, the evidence remains conflicting.
View Article and Find Full Text PDFMedicine (Baltimore)
September 2025
Department of Pediatrics, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, China.
Rationale: Weaver syndrome is a rare congenital overgrowth disorder characterized by a wide spectrum of clinical manifestations that often overlap with other overgrowth syndromes. It is primarily caused by pathogenic variants in the Enhancer of Zeste Homolog 2 (EZH2) gene on chromosome 7q36.1.
View Article and Find Full Text PDFFront Biosci (Landmark Ed)
August 2025
Department of Clinical Laboratory Medicine, The Fourth People's Hospital of Nanhai District of Foshan City, 528211 Foshan, Guangdong, China.
Background: Neonatal jaundice affects up to 60% of newborns, with pathological cases frequently associated with impaired bilirubin metabolism and gut microbiota dysbiosis. Although evidence implicates gut microbiota in bilirubin metabolism, the precise mechanisms remain incompletely characterized. This study investigated treatment-associated changes in gut microbiota composition, fecal metabolites, and liver function in neonates with hyperbilirubinemia.
View Article and Find Full Text PDFPediatr Surg Int
September 2025
Department of Pediatric Surgery, Capital Institute of Pediatrics-Peking University Teaching Hospital, Beijing, 100020, China.
Purpose: Biliary atresia (BA) patients presenting after 90 days of age face contentious treatment decisions between Kasai portoenterostomy and direct liver transplantation. This study evaluated outcomes of Kasai portoenterostomy in older BA patients to inform therapeutic decision-making.
Methods: A retrospective multicenter study analyzed 32 BA patients who underwent Kasai portoenterostomy beyond 90 days of age.